The U.S. has until May 20 to provide these assurances to the British High Court; if they are not satisfactory, he will receive a full appeal hearing in the U.K. Concurrently, Assange’s legal team is seeking an appeal with the European Court of Human Rights, which could possibly delay extradition further.

In other words, his fate remains uncertain, but this move by the British court is a decidedly good one. For more on Assange’s case, watch this episode of my show, Just Asking Questions, in which Zach Weissmueller and I interviewed Julian’s wife, Stella (who also happens to be an attorney who has worked on his case).

Abortion pill legality being considered: Today, the Supreme Court will hear arguments in a case involving the legality of mifepristone, one of the drugs used to induce abortions. The decision will most likely be announced in June, later in the term, and will have significant implications for whether the pill can be prescribed by mail or telemedicine.

“At issue is whether the [Food and Drug Administration (FDA)] acted appropriately in expanding access to the drug in 2016 and again in 2021,” reports The New York Times. “The court is also expected to consider whether the plaintiffs, a group of anti-abortion doctors and organizations, can show that they will suffer concrete harm if the pill remains widely available. Lawyers call this requirement standing.”

The Biden administration says, via brief, that the group of doctors has brought the lawsuit “based on speculative and attenuated injuries.”

Here’s a timeline of mifepristone approval, access, and lawsuits, spanning all the way back to 2000. More on how the FDA has determined mifepristone’s risk/safety here.

“Two-thirds (66%) of US adults say they oppose banning the use of mifepristone, or medication abortion, nationwide, and 62% oppose making it a crime for healthcare providers to mail abortion pills to patients in states where abortion is banned,” per a CNN writeup relying on KFF polling data from earlier this month. All of that is to say: abortion restrictions, particularly early-term procedures (which seemingly strike many people as less grotesque, more anodyne) have not proven to be a winning political issue for Republicans, so if the Supreme Court does move to restrict mifepristone, the political ripple effects may be major.